"With this acquisition, DHL Supply Chain will continue to strengthen its position and operating capacity in the high potential industry sector thanks to NTA's know-how, experience and coverage throughout the country," DHL said.

 Agustin Croche, president of DHL Supply Chain Mexico, said the acquisition will further support DHL Supply Chain's services in the Mexican market.

"It will significantly bolster our footprint in a strategically important industry vertical for DHL globally, bringing together NTA's proven operational capabilities, know-how and a team of healthcare experts. We expect to unlock significant growth opportunities for our customers and people", Croche added.

Currently, NTA makes more than 165,000 specialized deliveries annually, distributing more than 43,000 tons per year under the highest quality standards with a team of nearly 600 people that are always close to its customers. It maintains commercial agreements with all major airlines in Mexico to serve nationally the different stakeholders in the pharmaceutical product supply chain, including hospitals, sales representatives, pharmacies, and patients.

Mexico is the second largest pharmaceutical market in Latin America and shares a border and free trade agreement with the United States, the largest healthcare market globally.

In August 2022, the National Chamber of the Pharmaceutical Industry of Mexico (Canifarma) forecasted a growth of 36% in pharmaceutical production in 2022, the first year of double-digit growth within the last decade. Investments from international pharmaceutical companies are expected to increase.

Currently, in Mexico, DHL Supply Chain employs more than 12,500 logistics professionals in its operations.

Meanwhile, the cost of the transaction was not disclosed.